Byetta (exenatide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Byetta (exenatide), covering 2012-07-04 to 2012-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) [Phase 3]